Statins linked to raised risk of cataracts in study

September 19, 2013 by Steven Reinberg, Healthday Reporter
Statins linked to raised risk of cataracts in study
But heart benefits of these drugs are significant, expert says.

(HealthDay)—The statin medications that millions of adults take to lower their cholesterol levels may also raise their risk of developing cataracts, a new study suggests.

This is the latest of several studies looking for a link between statins such as Lipitor and Zocor and cataracts, a clouding of the lens of the eye. The results to date have been conflicting and inconclusive, the researchers note.

"Cataracts are a main cause of and blindness, specifically for the elderly," said lead investigator Dr. Ishak Mansi, of the VA North Texas Health System in Dallas.

"This study cannot identify that statins cause cataracts; rather, it identifies statin use as associated with a higher risk of being diagnosed with cataract," he added.

The report, published Sept. 19 in the online edition of JAMA Ophthalmology, involved almost 14,000 men and women, 6,972 pairs of statin users and nonusers, who were seen by the military from October 2001 to March 2010.

Those taking statins had a 27 percent increased risk of developing cataracts compared with nonusers, the researchers found.

"We tried to slice the data in different directions and look at our findings from different angles and approaches of analyses to ensure its consistency," Mansi said. "Consistently, statin use was associated with higher risk of cataract."

The findings should encourage patients to talk with their doctor about the risks and benefits of these drugs, but they shouldn't discontinue them based on this study, Mansi added.

"These medications have been a main tool in treatment of heart disease and should not be stopped because of a small higher risk of association with other diseases," he said.

The best way to prevent heart disease, however, is to modify your lifestyle, Mansi added.

"Effective medications are expected to have side effects; it is much better to do your best to lower your own by stopping smoking and keeping physically active than to take a pill to lower your risk of ," he said.

One expert doesn't think this study adds to the evidence of an association between statins and cataracts.

"The fact that many such observational studies gave conflicting results—some suggest statin use prevents cataract, while others, like this one, suggest that it might increase cataract development—means we have no idea," said Dr. Alfred Sommer, a professor of ophthalmology at the Johns Hopkins Bloomberg School of Public Health in Baltimore.

The only definitive way to answer the question is to randomize patients to use statins and not use statins, and then see what their risk of becomes, he said.

"But this would be unethical, because statins save lives," Sommer added.

Even if there is an increased risk of cataracts from statin use, which remains uncertain, people should still take statins if they are indicated, Sommer said.

"Statins reduce the risk of heart attacks, something that is frequently lethal," he said. Cataract surgery, on the other hand, is highly effective, and has only rare complications, he noted.

Explore further: Statins prevent cataracts

More information: For more information on statins, visit the U.S. National Library of Medicine.

Related Stories

Statins prevent cataracts

September 1, 2013
Statins lower the rate of cataract by 20 percent, according to research presented at the ESC Congress today by Professor John B. Kostis from New Jersey, USA. The risk of cataract was reduced by 50 percent when treatment was ...

Statins being overprescribed for growing number of kidney disease patients

September 10, 2013
A new analysis concludes that large numbers of patients in advanced stages of kidney disease are inappropriately being prescribed statins to lower their cholesterol – drugs that offer them no benefit and may increase other ...

Musculoskeletal conditions, injuries may be associated with statin use

June 3, 2013
Using cholesterol-lowering statins may be associated with musculoskeletal conditions, arthropathies (joint diseases) and injuries, according to a report published Online First by JAMA Internal Medicine.

Statin use linked to few side effects

July 9, 2013
the popular class of cholesterol-lowering drugs used widely to prevent recurrent heart disease or stroke as well as risk for having a first cardiac or stroke event—appear to cause few side effects, according to new research ...

Most statin-intolerant patients can eventually tolerate statins

September 9, 2013
Most patients who report statin intolerance, including muscle aches and other side effects from the cholesterol-lowering drugs, can actually tolerate drugs from this class on subsequent trials, according to research from ...

Should everyone over 65 take a statin?

August 28, 2013
(HealthDay)—Men and women over 65 who are at risk for cardiovascular disease but don't have any known heart problems might benefit from cholesterol-lowering drugs, a new study suggests.

Recommended for you

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

New study offers added hope for patients awaiting corneal transplants

January 9, 2018
New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery to correct eye problems ...

Diabetic blindness caused and reversed "trapped" immune cells in rodent retinas

January 3, 2018
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels ...

Ophthalmologists increasingly dissatisfied with electronic health records

December 29, 2017
Ophthalmologists' use of electronic health records (EHR) systems for storing and accessing patients' medical histories more than doubled between 2006 and 2016, while their perceptions of financial and clinical productivity ...

Higher omega-3 fatty acid intake tied to lower glaucoma risk

December 26, 2017
(HealthDay)—Increased daily intake of ω-3 fatty acids is associated with lower odds of glaucoma, but higher levels of total polyunsaturated fatty acid (PUFA) intake are associated with higher odds of developing glaucoma, ...

Protein analysis allows for treatment of eye-disease symptoms with existing drugs

December 21, 2017
Demonstrating the potential of precision health, a team led by a researcher at the Stanford University School of Medicine has matched existing drugs to errant proteins expressed by patients with a rare eye disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.